Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07358351 · ClinicalTrials.gov registry record
Feasibility of Robotic Instrument Guidance System to Perform Safe Ultrasound-Guided Percutaneous Procedures During Routine Medical Procedures.
A clinical trial of Percutaneous Access, sponsored by Mendaera.
- Active
- Registry status
- 46
- Enrollment target
- 1
- Study location
NCT07358351: Active study of Percutaneous Access, sponsored by Mendaera.
NCT07358351 is a study of Percutaneous Access that is active but no longer recruiting, run by Mendaera. The registered enrollment target is 46 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07358351, a study of Percutaneous Access, is active but no longer recruiting, sponsored by Mendaera.
- ACTIVE NOT RECRUITING
- Registry status
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The Mendaera Guidance System ("Study Device") is intended to provide guidance for precise instrument placement of common percutaneous devices by positioning the device relative to the ultrasound transducer and the resulting image during a diagnostic or therapeutic procedure. After instrument placement is achieved, investigator will perform any further clinical tasks, procedures, or treatment using standard of care. The target population for whom this device is intended includes participants requiring ultrasound guided, percutaneous procedures. Participants who are scheduled to undergo an ultrasound-guided procedure will be consented and enrolled in the study. Prior to the study procedure, participants should be prepared for ultrasound-guided procedure using standard of care. Once the investigator determines that an ultrasound-guided procedure can be performed, the compatible percutaneous instrument will be connected to the Study Device, and the investigator may proceed to utilize the System to perform targeting and depth tracking of the instrument. Once access has been achieved, Participation will conclude after the first follow-up which is anticipated to be within 24±12 hours.
Conditions Studied
Interventions
- DEVICE Mendaera Guidance System
Study Locations (1)
California
- Mendaera, Inc - San Mateo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2026-02 |
What the registry record for NCT07358351 still lists
NCT07358351 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 1 condition, with Percutaneous Access appearing as the primary indexed condition, and to 1 intervention - of which Mendaera Guidance System is the first listed.
NCT07358351 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07358351 about?
NCT07358351 is a clinical study titled "Feasibility of Robotic Instrument Guidance System to Perform Safe Ultrasound-Guided Percutaneous Procedures During Routine Medical Procedures.". The Mendaera Guidance System ("Study Device") is intended to provide guidance for precise instrument placement of common percutaneous devices by positioning the device relative to the ultrasound transducer and the resulting image during a diagnostic or therapeutic procedure. After instrument placeme...
What is the current status of trial NCT07358351?
This trial is currently active not recruiting. The enrollment target is 46 participants. The study started on 2025-12-03. Estimated completion is 2026-02.
What conditions does trial NCT07358351 study?
This clinical trial studies the following conditions: Percutaneous Access.
What interventions are being tested in trial NCT07358351?
The interventions under investigation include: Mendaera Guidance System (DEVICE).
Who is sponsoring clinical trial NCT07358351?
This trial is sponsored by Mendaera, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07358351 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI